ConductScience.org, home

Paper2327770

Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis.

Hughes WT and 4 others. Antimicrob Agents Chemother, 1990. Cited by 120 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Papers, record 2327770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2327770

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
120
iCite
Relative citation ratio, by iCite
5.69
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hughes WTW T
2Gray VLV L
3Gutteridge WEW E
4Latter VSV S
5Pudney MM

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
NaphthoquinonesMajor topic
Pneumonia, PneumocystisMajor topic
Animals
Atovaquone
Dexamethasone
Lung
Male
Rats
Rats, Inbred Strains
Tetracyclines
Trimethoprim, Sulfamethoxazole Drug Combination

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16037033Naphthoquinone antimalarials. XXIX. 2-hydroxy-3-(omega-cyclohexylalkyl)-1,4-naphthoquinones.J Med Chem1967https://conductscience.org/library/papers/6037033PubMed
24365115Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4365115PubMed
3934316Chemotherapy of Theileria parva infection.Nature1976https://conductscience.org/library/papers/934316PubMed
4412099Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.N Engl J Med1977https://conductscience.org/library/papers/412099PubMed
5205176Lipid peroxidation and the generation of free radicals, superoxide anion, and hydrogen peroxide in beta-lapachone-treated Trypanosoma cruzi epimastigotes.Arch Biochem Biophys1978https://conductscience.org/library/papers/205176PubMed
63920634Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity.Parasitology1985https://conductscience.org/library/papers/3920634PubMed
7367298In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi.Ann Trop Med Parasitol1978https://conductscience.org/library/papers/367298PubMed
833002Superoxide anion production and trypanocidal action of naphthoquinones on Trypanosoma cruzi.Comp Biochem Physiol C Comp Pharmacol1978https://conductscience.org/library/papers/33002PubMed
9315754Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/315754PubMed
106331460Potent and selective hydroxynaphthoquinone inhibitors of mitochondrial electron transport in Eimeria tenella (Apicomplexa: Coccidia).Biochem Pharmacol1984https://conductscience.org/library/papers/6331460PubMed
11702049An approach to the development of new drugs for African trypanosomiasis.J Exp Med1978https://conductscience.org/library/papers/702049PubMed

Download CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.

PMIDTitleJournalYearIn PapersSource
31265248Design and Application of a High-Throughput, High-Content Screening System for Natural Product Inhibitors of the Human Parasite Trichomonas vaginalis.ACS Infect Dis2019https://conductscience.org/library/papers/31265248PubMed
23758163How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria-targeted drugs.Br J Pharmacol2013https://conductscience.org/library/papers/23758163PubMed
17383607Parameters determining the relative efficacy of hydroxy-naphthoquinone inhibitors of the cytochrome bc1 complex.Biochim Biophys Acta2007https://conductscience.org/library/papers/17383607PubMed
11959541Antiparasitic agent atovaquone.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/11959541PubMed
10681344Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. carinii.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10681344PubMed
10602716Effects of atovaquone and diospyrin-based drugs on ubiquinone biosynthesis in Pneumocystis carinii organisms.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10602716PubMed
10348748A mechanism for the synergistic antimalarial action of atovaquone and proguanil.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10348748PubMed
9624466Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9624466PubMed
9457427The lipids of Pneumocystis carinii.Clin Microbiol Rev1998https://conductscience.org/library/papers/9457427PubMed
8980779Efficacy of lasalocid against murine Pneumocystis carinii pneumonitis.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/8980779PubMed
8851575Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8851575PubMed
8851570Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8851570PubMed
8849260Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8849260PubMed
8619570Antipneumocystis activity of 17C91, a prodrug of atovaquone.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/8619570PubMed
8556494Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.Clin Diagn Lab Immunol1994https://conductscience.org/library/papers/8556494PubMed
8504623Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.Clin Pharmacokinet1993https://conductscience.org/library/papers/8504623PubMed
8363369Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8363369PubMed
8285620In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8285620PubMed
8148213Examination of some factors responsible for a food-induced increase in absorption of atovaquone.Br J Clin Pharmacol1994https://conductscience.org/library/papers/8148213PubMed
8067749Effects of pentamidine isethionate on Saccharomyces cerevisiae.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8067749PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2327770

GET https://conductscience.org/api/papers/v1/2327770/cited_by?page=2